background
sever
acut
respiratori
syndrom
sar
caus
infect
sarsassoci
coronaviru
cov
amino
acid
residu
spike
glycoprotein
sarscov
contain
domin
epitop
antivir
antibodi
ab
patient
sera
object
develop
evalu
elisa
system
detect
anti
ab
patient
sera
studi
design
express
recombin
e
coli
evalu
sensit
specif
elisa
system
base
polypeptid
result
elisa
detect
igg
ab
serum
sampl
hospit
patient
probabl
sar
result
close
correl
obtain
virusbas
elisa
r
k
differenti
anti
igg
respons
observ
amongst
sar
patient
produc
anti
ab
earli
infect
other
fail
make
igg
ab
polypeptid
none
serum
sampl
healthi
blood
donor
posit
assay
conclus
elisa
detect
anti
igg
ab
high
sensit
specif
sever
acut
respiratori
syndrom
sar
caus
sarsassoci
coronaviru
sarscov
envelop
positivestrand
rna
viru
coronavirida
famili
rota
et
al
peiri
et
al
genom
sarscov
encod
sever
structur
protein
includ
spike
glycoprotein
nucleocapsid
protein
membran
protein
envelop
protein
marra
et
al
membran
fusion
sarscov
host
cell
mediat
glycoprotein
xiao
et
al
dimitrov
wong
et
al
wang
et
al
sui
et
al
consist
amino
acid
residu
approxim
homolog
human
cov
spiga
et
al
ho
et
al
subunit
amino
acid
glycoprotein
contain
receptorbind
domain
appar
main
target
neutral
ab
patient
sera
xiao
et
al
sui
et
al
wong
et
al
wang
et
al
babcock
et
al
western
blot
wb
indirect
immunofluoresc
assay
develop
detect
ab
protein
chang
et
al
wu
et
al
woo
et
al
ho
et
al
et
al
howev
far
enzymelink
immunosorb
assay
elisa
avail
easier
sensit
detect
anti
ab
computerassist
analysi
suggest
amino
acid
residu
glycoprotein
sarscov
larg
solvent
access
like
contain
domin
b
cell
epitop
coincid
recent
publish
result
lu
et
al
show
residu
protein
sarscov
contain
domin
epitop
anti
ab
patient
sera
determin
wb
assay
sequenc
outsid
region
rel
poorli
recogn
patient
sera
also
support
find
zhou
et
al
residu
protein
sarscov
elicit
neutral
ab
viru
studi
fragment
express
e
coli
use
ag
elisa
system
detect
anti
ab
restrict
enzym
ligas
invitrogen
usa
kit
dna
extract
purif
qiagen
hilden
germani
e
coli
strain
obtain
novagen
germani
invitrogen
usa
respect
complementari
dna
encod
full
length
sarscov
gift
china
cdc
march
major
outbreak
sar
taken
place
beij
china
collect
sequenti
blood
sampl
sampl
total
patient
sex
year
age
averag
year
admit
first
affili
hospit
peke
univers
beij
china
april
june
patient
fulfil
definit
probabl
sar
fever
c
higher
cough
new
pulmonari
infiltr
chest
radiographi
absenc
altern
diagnosi
explain
clinic
present
blood
sampl
process
within
h
collect
patient
sera
test
antisarscov
igg
ab
use
elisa
kit
produc
huada
institut
see
total
serum
sampl
patient
randomli
select
patient
group
test
use
elisa
kit
addit
sera
healthi
blood
donor
sex
year
age
collect
may
juli
provid
beij
red
cross
blood
center
small
outbreak
sar
took
place
april
involv
nine
patient
anhui
beij
china
sequenti
serum
sampl
four
confirm
patient
second
third
gener
case
admit
ditan
hospit
april
june
also
includ
studi
dna
code
sar
cov
protein
pcr
amplifi
use
high
fidel
taq
dna
polymeras
takara
biotech
co
ltd
japan
sequenc
primer
employ
pcr
reaction
cgc
gga
tcc
atg
ccc
ttt
gag
aga
gac
ata
tct
forward
primer
carri
bamhi
restrict
site
ccc
gaa
ttc
tta
aat
gtc
gca
ctc
ata
aga
agt
g
revers
primer
carri
ecori
site
pcr
product
gelpurifi
clone
express
vector
novagen
germani
result
construct
encod
fragment
histidin
tag
n
terminu
dna
sequenc
insert
determin
compar
gene
sequenc
sarscov
strain
urbani
access
number
use
dnastar
softwar
transform
e
coli
cell
expans
bacteri
coloni
harbor
plasmid
inocul
medium
contain
kanamycin
gml
cultur
continu
shake
c
appropri
densiti
iptg
ad
final
concentr
mm
induc
express
recombin
protein
h
centrifug
g
min
pellet
resuspend
pb
subject
sonic
ice
bath
min
inclus
bodi
solubil
urea
centrifug
g
c
min
supernat
appli
equilibr
ni
column
novagen
germani
oncolumn
refold
procedur
protein
bound
column
elut
mm
imidazol
trisbuff
salin
ph
elut
fraction
examin
sdspage
protein
either
stain
coomassi
blue
transfer
nitrocellulos
membran
wb
assay
nitrocellulos
membran
protein
band
transfer
block
room
temperatur
h
block
solut
nonfat
dri
milk
incub
h
room
temperatur
serum
sampl
wash
trisbuff
salin
tb
ph
contain
tween
membran
incub
hrplabel
goat
antihuman
igg
ab
zhongshan
biotech
co
china
diaminobenzidin
tetrahydrochlorid
dab
sigma
use
visual
reaction
elisa
plate
nunc
demark
coat
c
overnight
recombin
protein
pmolwel
carbon
buffer
ph
immedi
use
coat
plate
incub
block
solut
bsa
pb
h
c
wash
time
pb
contain
tween
pbst
serum
sampl
dilut
lwell
ad
triplic
incub
min
c
wash
pbst
horseradish
peroxidas
hrp
label
goat
antihuman
igg
ab
ad
incub
h
c
orthophenylenediamin
opd
substrat
use
lwell
substrat
h
solut
stop
buffer
optic
densiti
od
immedi
read
nm
elisa
use
kit
produc
huada
institut
beij
china
manufactur
instruct
follow
briefli
dilut
buffer
lwell
ad
precoat
well
follow
l
serum
incub
min
c
wash
hrplabel
detect
ab
dilut
dispens
lwell
incub
min
c
wash
substrat
buffer
contain
abt
azinodi
sulfon
ad
allow
develop
min
stop
buffer
ad
plate
read
nm
experi
describ
repeat
least
three
time
result
obtain
use
recombin
proteinbas
elisa
sarscovspecif
kit
compar
use
correl
modul
microsoft
excel
softwar
cohen
kappa
test
perform
analyz
agreement
result
two
elisa
kit
use
spss
softwar
complementari
dna
encod
sarscov
clone
express
vector
express
e
coli
histagcontain
recombin
protein
purifi
homogen
use
ni
column
sdspage
analysi
affin
purifi
product
reveal
protein
band
expect
molecular
weight
fig
wb
assay
convalesc
serum
sar
patient
ptlx
antihistag
mab
specif
recogn
recombin
fig
subsequ
studi
recombin
employ
coat
ing
ag
elisa
kit
hrplabel
goatantihuman
igg
ab
secondari
ab
checkerboard
titrat
experi
carri
optim
concentr
coat
ag
secondari
ab
data
shown
sarscovspecif
elisa
kit
develop
huada
institut
beij
china
licens
ministri
public
health
china
employ
lysat
sarscovinfect
cell
coat
ag
wide
use
china
sarscovspecif
ab
test
reliabl
result
use
huada
kit
analyz
sequenti
serum
sampl
total
sera
hospit
patient
probabl
sar
result
summar
tabl
half
patient
seroconvert
igg
ab
sarscov
day
onset
ill
nearli
produc
virusspecif
serum
ab
day
sera
three
convalesc
sar
patient
two
healthi
individu
serial
dilut
test
elisa
detect
anti
igg
ab
specif
sensit
manner
reactiv
end
point
dilut
patient
sera
fig
serum
sampl
healthi
blood
donor
subsequ
screen
none
posit
fig
suggest
high
specif
system
sequenti
serum
sampl
total
dilut
patient
randomli
select
abovement
patient
set
probabl
sar
analyz
use
assay
posit
fig
huada
kit
detect
antivir
igg
ab
sampl
fig
posit
assay
virusbas
elisa
result
plot
linear
correl
first
degre
regress
r
observ
fig
fig
sensit
elisa
elisa
plate
coat
recombin
serum
sampl
convalesc
sar
patient
healthi
individu
serial
dilut
dispens
triplic
well
hrplabel
goat
antihuman
igg
use
secondari
ab
opd
substrat
result
express
absorb
read
nm
wavelength
fig
comparison
virusbas
elisa
result
elisa
kit
use
screen
serum
sampl
healthi
blood
donor
b
patient
collect
day
onset
ill
probabl
sar
serum
sampl
fold
dilut
result
express
absorb
read
nm
wavelength
cutoff
valu
elisa
result
obtain
huada
kit
shown
c
comparison
case
serum
sampl
fold
dilut
result
express
absorb
read
wavelength
nm
cutoff
valu
bar
repres
one
serum
sampl
sampl
patient
group
togeth
order
collect
time
day
onset
ill
cohen
kappa
test
also
confirm
agreement
time
cours
igg
respons
protein
whole
viru
patient
compar
fig
b
sera
patient
contain
high
titer
anti
low
titer
antiviru
igg
ab
contrast
patient
high
respond
whole
viru
low
respond
patient
seroconvert
day
onset
symptom
suggest
possibl
case
sarscov
infect
acquir
hospit
ward
patient
remain
neg
test
month
onset
ill
eventu
exclud
sar
patient
virusbas
elisa
kit
employ
screen
sera
addit
sar
patient
infect
april
three
high
respond
protein
one
respond
poorli
strongli
whole
viru
fig
patient
anti
serum
ab
appear
earlier
specif
viral
protein
specif
sensit
detect
method
antivir
ab
patient
sera
great
valu
diagnosi
well
research
virusbas
assay
advantag
abl
detect
ab
specif
structur
compon
viru
hand
recombin
proteinbas
test
would
allow
analysi
antivir
humor
immun
much
detail
protein
sarscov
heavili
glycosyl
contain
mani
disulfid
bond
spiga
et
al
krokhin
et
al
tripet
et
al
ying
et
al
difficult
howev
obtain
glycoprotein
express
eukaryot
system
would
otherwis
ideal
detect
anti
ab
vitro
fulllength
protein
express
prokaryot
system
often
insolubl
therefor
unsuit
coat
ag
elisa
system
oncolumn
refold
procedur
allow
correct
format
disulfid
bond
fragment
produc
solubl
recombin
protein
reason
high
concentr
data
shown
result
report
herein
indic
elisa
detect
anti
ab
patient
sera
high
sensit
specif
suggest
nglycan
glycoprotein
could
signific
effect
antigen
presenc
nglycan
contribut
correct
fold
biolog
function
glycoprotein
howev
recent
publish
result
indic
bacteri
express
fragment
protein
nonglycosyl
could
maintain
antigen
zhou
et
al
lu
et
al
addit
neutral
ab
success
rais
mice
immun
use
prokaryot
express
sarscov
zhou
et
al
studi
wound
sar
patient
develop
strong
igg
respons
glycoprotein
sarscov
anti
ab
significantli
higher
titer
structur
protein
viru
eg
situat
proteinbas
elisa
would
sensit
virusbas
assay
detect
antivir
ab
also
case
poorli
recogn
ab
patient
sera
eg
fig
emphas
howev
polypeptid
cover
less
protein
sequenc
neg
result
rule
possibl
presenc
anti
ab
epitop
outsid
region
protein
moreov
xu
et
al
report
rel
high
frequenc
variat
gene
sarscov
natur
variabl
protein
might
also
affect
valid
elisa
although
antigen
variat
yet
fulli
character
